GW Pharmaceuticals EBITDA margin
Was ist das EBITDA margin von GW Pharmaceuticals?
EBITDA margin von GW Pharmaceuticals ist -9.24%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu GW Pharmaceuticals
Unternehmen mit ebitda margin ähnlich GW Pharmaceuticals
- TransMedics hat EBITDA margin von -9.29%
- Vinco hat EBITDA margin von -9.28%
- Netlist hat EBITDA margin von -9.26%
- Besunyen hat EBITDA margin von -9.26%
- Diagnostic Medical Systems S.A hat EBITDA margin von -9.25%
- Roblox hat EBITDA margin von -9.25%
- GW Pharmaceuticals hat EBITDA margin von -9.24%
- SML Isuzu hat EBITDA margin von -9.22%
- Nanoxplore Inc hat EBITDA margin von -9.22%
- Hong Kong Food Investment hat EBITDA margin von -9.22%
- UFO Moviez India hat EBITDA margin von -9.21%
- Uniphos Enterprises hat EBITDA margin von -9.19%
- China Technology Solar Power hat EBITDA margin von -9.18%